| Quarterly Financials | Jun 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 540 | 645 | 636 | 647 | 687 | 699 | 699 | 708 | 758 | 781 | 783 | 824 | 962 | 1,014 | 1,092 |
| Expenses | 413 | 535 | 511 | 515 | 525 | 534 | 548 | 561 | 589 | 608 | 606 | 664 | 783 | 860 | 889 |
| EBITDA | 127 | 111 | 125 | 133 | 162 | 164 | 151 | 148 | 170 | 173 | 177 | 160 | 179 | 154 | 203 |
| Operating Profit % | 21 % | 15 % | 16 % | 19 % | 22 % | 21 % | 19 % | 18 % | 18 % | 20 % | 20 % | 17 % | 17 % | 14 % | 16 % |
| Depreciation | 10 | 20 | 20 | 20 | 18 | 19 | 20 | 19 | 20 | 21 | 22 | 23 | 40 | 42 | 44 |
| Interest | 2 | 12 | 13 | 12 | 12 | 12 | 12 | 4 | 3 | 3 | 4 | 4 | 5 | 7 | 6 |
| Profit Before Tax | 115 | 79 | 93 | 101 | 132 | 134 | 120 | 124 | 146 | 149 | 152 | 133 | 135 | 105 | 153 |
| Tax | 29 | 30 | 24 | 26 | 34 | 39 | 32 | 32 | 37 | 32 | 36 | 31 | 32 | 25 | 37 |
| Net Profit | 86 | 49 | 68 | 75 | 99 | 95 | 88 | 92 | 110 | 118 | 116 | 102 | 103 | 80 | 116 |
| EPS in ₹ | 3.88 | 2.20 | 3.09 | 3.38 | 4.45 | 4.27 | 3.79 | 3.84 | 4.59 | 4.91 | 4.86 | 4.26 | 4.29 | 3.32 | 4.84 |
Indegene
Indegene
553.75
+8.50
(1.56%)
Market Cap
13,342.84 Cr
PE Ratio
32.72
Volume
10,47,239.00
Day High - Low
567.80 - 542.55
52W High-Low
596.80 - 414.00
Key Fundamentals
Market Cap
13,342.84 Cr
EPS
16.72
PE Ratio
32.72
PB Ratio
4.18
Book Value
130.27
EBITDA
691.00
Dividend Yield
0.41 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
12.78
Debt to Equity
0.04
Analyst Rating and Forecast
- By Refinitiv from7 analysts
Actual
Company News
View All News
Indegene reports ₹1,162 million consolidated net profit for Q1FY27, stable year-on-year. The company fully utilized its IPO proceeds and proposed a ₹2.25 dividend per share.
Indegene BRSR FY26 highlights
Jul 17, 2026
Jul 17, 2026Indegene Ltd filed its BRSR for FY26, reporting 98.47% export turnover and SBTi-validated emission targets. The company achieved a 20.63% reduction in Scope 1 and 2 emissions.
Indegene declares ₹2.25 dividend, sets AGM dateJul 15, 2026
Jul 15, 2026Indegene Limited announced a final dividend of ₹2.25 per share for FY26 and scheduled its AGM for August 13, 2026. The record date is July 31, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
410.20 | #1 16,558.51 | 73.39 | #1 3,809.40 | 2.56 | 317 | -110.38 | 46.60 | |
553.75 | #2 13,342.84 | #2 32.72 | #2 3,582.50 | #3 21.58 | #1 401 | #4 -0.17 | 69.37 | |
309.85 | 8,171.38 | -31.43 | 21.00 | 19.32 | -276 | -3.87 | 50.17 | |
642.25 | 2,868.89 | 35.09 | 322.30 | 0.22 | 41 | 112.87 | 67.47 | |
22.39 | 331.22 | #1 30.62 | 54.19 | #1 431.27 | 11 | 189.80 | 47.18 | |
77.60 | 155.79 | 145.53 | 61.54 | 29.56 | 2 | #1 238.46 | 57.94 | |
60.53 | 142.52 | -8.38 | 733.54 | -9.05 | -21 | -35.54 | 50.65 | |
16.30 | 23.50 | 33.09 | 56.10 | -33.21 | 1 | -88.00 | 22.25 | |
24.03 | 17.10 | 160.20 | 1.82 | -13.33 | 0 | -333.33 | 17.60 |
Growth Rate
Revenue Growth
21.58 %
Net Income Growth
-1.38 %
Cash Flow Change
47.27 %
ROE
-17.81 %
ROCE
-24.25 %
EBITDA Margin (Avg.)
-11.39 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 329 | 600 | 596 | 1,354 | 2,204 | 2,546 | 3,326 | 4,620 |
| Fixed Assets | 104 | 119 | 86 | 138 | 664 | 646 | 678 | 1,812 |
| Current Assets | 185 | 418 | 459 | 1,130 | 1,449 | 1,791 | 2,530 | 2,618 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 12 |
| Investments | 0 | 13 | 0 | 120 | 614 | 797 | 1,290 | 1,100 |
| Other Assets | 225 | 468 | 510 | 1,096 | 926 | 1,103 | 1,355 | 1,697 |
| Total Equity & Liabilities | 329 | 600 | 596 | 1,354 | 2,204 | 2,546 | 3,326 | 4,620 |
| Current Liabilities | 158 | 247 | 199 | 440 | 489 | 611 | 565 | 1,086 |
| Non Current Liabilities | 18 | 369 | 64 | 149 | 651 | 506 | 146 | 395 |
| Total Equity | 152 | -16 | 333 | 764 | 1,064 | 1,429 | 2,616 | 3,139 |
| Reserve & Surplus | 73 | -105 | 324 | 764 | 1,020 | 1,385 | 2,567 | 3,090 |
| Share Capital | 79 | 0 | 0 | 0 | 44 | 44 | 48 | 48 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 25 | 143 | -41 | 373 | -433 | 115 | 52 | 60 |
| Investing Activities | -18 | -16 | -81 | -158 | -896 | -327 | -677 | -508 |
| Operating Activities | 65 | 22 | 172 | 297 | 130 | 508 | 442 | 651 |
| Financing Activities | -21 | 136 | -132 | 234 | 333 | -66 | 288 | -83 |
Share Holding
| % Holding | Dec 2022 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 3.56 % | 0.00 % | 0.00 % | 3.79 % | 4.82 % | 5.03 % | 5.24 % | 10.05 % | 11.30 % | 11.48 % | 10.27 % | 9.91 % |
| DIIs | 0.00 % | 5.33 % | 0.00 % | 0.00 % | 3.84 % | 3.17 % | 3.98 % | 4.96 % | 7.20 % | 6.96 % | 8.07 % | 8.30 % | 8.74 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 11.38 % | 0.00 % | 0.00 % | 24.67 % | 24.32 % | 26.41 % | 11.34 % | 13.51 % | 13.28 % | 12.45 % | 12.57 % | 12.49 % |
| Others | 100.00 % | 79.73 % | 100.00 % | 100.00 % | 67.70 % | 67.69 % | 64.58 % | 78.45 % | 69.24 % | 68.46 % | 68.00 % | 68.87 % | 68.86 % |
| No of Share Holders | 44 | 4,43,785 | 82 | 82 | 2,03,599 | 1,51,440 | 1,53,789 | 1,44,708 | 1,51,997 | 1,51,809 | 1,47,182 | 1,42,119 | 1,38,533 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 2.25 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 | 0.41 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Aug 2026 |  Annual General Meeting | NA | 13 Aug 2026 | 507.20 | 544.45 |
| 17 Nov 2022 |  Change Of Name | NA | 17 Nov 2022 | 0.00 | 0.00 |
| 06 Sept 2024 | Annual General Meeting | NA | 06 Sept 2024 | 554.85 | 608.85 |
| 28 Oct 2024 |  Quarterly Result Announcement | NA | 28 Oct 2024 | 653.25 | 675.45 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 663.05 | 622.10 |
| 28 Apr 2025 | Quarterly Result Announcement | NA | 28 Apr 2025 | 570.25 | 567.40 |
| 13 Jun 2025 |  Dividend | ₹ 2.00 /share | 13 Jun 2025 | 567.40 | 598.55 |
| 26 Jun 2025 | Annual General Meeting | NA | 26 Jun 2025 | 609.15 | 580.55 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 558.95 | 546.55 |
| 30 Oct 2025 | Quarterly Result Announcement | NA | 30 Oct 2025 | 554.75 | 545.50 |
| 29 Jan 2026 | Quarterly Result Announcement | NA | 29 Jan 2026 | 480.90 | 475.45 |
| 29 Apr 2026 | Quarterly Result Announcement | NA | 29 Apr 2026 | 482.65 | 499.75 |
| 30 Jul 2026 | Quarterly Result Announcement | NA | 30 Jul 2026 | 495.95 | 523.60 |
| 31 Jul 2026 | Dividend | ₹ 2.25 /share | 31 Jul 2026 | 499.75 | 514.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency Report5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
5 days agoUnaudited Financial Results For The Quarter Ended June 30 20265 days ago
5 days agoBoard Meeting Outcome for For The Meeting Of Board Of Directors Held On 30Th July 20265 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2026
Jul 18, 2026Letter To Shareholders In Relation To Annual Report Of The Company For The Financial Year 2025-26Jul 17, 2026
Jul 17, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 17, 2026
Jul 17, 2026Reg. 34 (1) Annual Report.Jul 17, 2026
Jul 17, 2026Notice Of The 28Th Annual General Meeting Of The CompanyJul 17, 2026
Jul 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2026
Jul 16, 2026Record Date For Payment Of Final DividendJul 15, 2026
Jul 15, 2026Board Meeting Outcome for Outcome Of Board MeetingJul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 10, 2026
Jul 10, 2026Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 Along With The Limited Review Report Of The Auditors Thereon.Jul 10, 2026
Jul 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Jul 10, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2026
Jun 11, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2026
Jun 03, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 06, 2026
May 06, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2026
May 05, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 04, 2026
May 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 30, 2026
Apr 30, 2026 Intimation Of Outcome Of Board MeetingApr 29, 2026
Apr 29, 2026Intimation Of Opening Of Trading WindowApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportApr 29, 2026
Apr 29, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Investor PresentationApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2026
Apr 29, 2026Board Meeting Outcome for Outcome Of Board MeetingApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Apr 22, 2026Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company And Recommendation Of Final Dividend For The Year Ended March 31 2026.Apr 21, 2026
Apr 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Intimation Of AgreementApr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Clarification LetterMar 24, 2026
Mar 24, 2026Clarification sought from Indegene LtdMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 18, 2026
Mar 18, 2026Clarification LetterMar 16, 2026
Mar 16, 2026Clarification sought from Indegene LtdMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Mar 13, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 66.76
ATR(14)
Volatile 18.70
STOCH(9,6)
Neutral 75.55
STOCH RSI(14)
Overbought 83.76
MACD(12,26)
Bullish 3.87
ADX(14)
Weak Trend 22.35
UO(9)
Bearish 53.74
ROC(12)
Uptrend And Accelerating 6.71
WillR(14)
Overbought -13.17
About Indegene
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more
Listing Date
13 May, 2024(2 Years, 2 Months, 23 Days)
Website
Chairperson NameManish Gupta
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
